Despite claims by the industry and some politicians, there are no clinically meaningful differences among the variety of vaccines approved under
emergency use authorisation (EUA).
The global community is conducting a rapid vaccination program against the SARS.Cov-2 virus, using several vaccines, authorised for emergency use. To date, the percentages of adults vaccinated
vary between less than 2% to over 90% in different countries.
There is considerable evidence that vitamin D reduces the risk and severity of COVID-19 (
Mercola 2020 ;
Wimalawansa, 2020). More than 50 clinical studies have published confirming that high doses of vitamin D administered early in persons with COVID-19 significantly reduce complications and the need for ICU admissions.
The SARS-CoV-2 infection (COVID-19) affected the entire world; many died, millions got sick, and the misery continues. Second and third waves of SARS.Cov-2 infection are devastating most countries.